New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
10:25 EDTMYLMylan receives final approval from FDA for ANDA for generic Maxalt MLT tablets
Mylan announced that its subsidiary Mylan Pharmaceuticals has received final approval from the FDA for its Abbreviated New Drug Applications for Rizatriptan Benzoate Orally Disintegrating Tablets, 5 mg (base) and 10 mg, and Rizatriptan Benzoate Tablets, 5 mg and 10 mg. These products are the generic versions of Merck's Maxalt MLT Tablets and Maxalt Tablets, respectively, and are indicated for the acute treatment of migraine with or without aura in adults.
News For MYL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
08:04 EDTMYLGerman fund pressured to sell Mylan stake over drug used in executions, FT says
Subscribe for More Information
07:20 EDTMYLInternational Continence Society to hold annual meeting
ICS Annual Meeting 2014 is being held in Rio de Janeiro, Brazil on October 20-24.
October 8, 2014
06:47 EDTMYLLawmakers may push for new regulations on generic drug makers, NY Times says
After the prices of some generic drugs soared more than 1,000% over the last year, two influential members of Congress are probing the sector and threatening to look to impose new regulations on it, according to The New York Times. Generic drug makers include Teva (TEVA), Mylan (MYL), Actavis (ACT), and Lannett (LCI).Reference Link
October 7, 2014
10:56 EDTMYLOptions with increasing implied volatility
Subscribe for More Information
October 6, 2014
11:09 EDTMYLOptions with increasing implied volatility
Subscribe for More Information
07:30 EDTMYLMylan launches generic Combivir
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use